{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:04:13Z","timestamp":1790672653762,"version":"4.1.0"},"reference-count":144,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1309\/ajcpppz1wfvgne4a","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T20:22:04Z","timestamp":1268684524000},"page":"602-615","source":"Crossref","is-referenced-by-count":24,"title":["Molecular Pathology of Myeloproliferative Neoplasms"],"prefix":"10.1093","volume":"133","author":[{"given":"Jeffery M.","family":"Klco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Vij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike H.","family":"Kreisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjum","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Frater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"2016010322452388000_133.4.602.1","unstructured":"Jaffe ES Harris NL Stein H , eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours."},{"key":"2016010322452388000_133.4.602.2","unstructured":"Swerdlow SH Campo E Harris NL , eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008."},{"key":"2016010322452388000_133.4.602.3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404955"},{"key":"2016010322452388000_133.4.602.4","unstructured":"Bennett J . Two cases of disease and enlargement of the spleen in which death took place from the presence of purulent matter in the blood. Edinburgh Med Surg J. 1845;64:413\u2013423."},{"key":"2016010322452388000_133.4.602.5","unstructured":"Virchow R . Weisses Blut. Froiep\u2019s Notizen. 1845;36:151\u2013156."},{"key":"2016010322452388000_133.4.602.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00061-7"},{"key":"2016010322452388000_133.4.602.7","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199704040-00009"},{"key":"2016010322452388000_133.4.602.8","doi-asserted-by":"crossref","unstructured":"Spiers AS Bain BJ Turner JE . The peripheral blood in chronic granulocytic leukaemia: study of 50 untreated Philadelphia-positive cases. Scand J Haematol. 1977;18:25\u201338.","DOI":"10.1111\/j.1600-0609.1977.tb01474.x"},{"key":"2016010322452388000_133.4.602.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb03675.x"},{"key":"2016010322452388000_133.4.602.10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21291"},{"key":"2016010322452388000_133.4.602.11","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"2016010322452388000_133.4.602.12","doi-asserted-by":"publisher","DOI":"10.1038\/306277a0"},{"key":"2016010322452388000_133.4.602.13","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(79)90063-8"},{"key":"2016010322452388000_133.4.602.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402223"},{"key":"2016010322452388000_133.4.602.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.7.2084"},{"key":"2016010322452388000_133.4.602.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00357-4"},{"key":"2016010322452388000_133.4.602.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.10.015"},{"key":"2016010322452388000_133.4.602.18","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-561"},{"key":"2016010322452388000_133.4.602.19","doi-asserted-by":"crossref","unstructured":"Deininger MW Goldman JM Lydon N The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL\u2013positive cells. Blood. 1997;90:3691\u20133698.","DOI":"10.1182\/blood.V90.9.3691"},{"key":"2016010322452388000_133.4.602.20","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1997.0155"},{"key":"2016010322452388000_133.4.602.21","doi-asserted-by":"crossref","unstructured":"Heinrich MC Griffith DJ Druker BJ Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood. 2000;96:925\u2013932.","DOI":"10.1182\/blood.V96.3.925.015k50_925_932"},{"key":"2016010322452388000_133.4.602.22","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007700629728"},{"key":"2016010322452388000_133.4.602.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"2016010322452388000_133.4.602.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"2016010322452388000_133.4.602.25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21096"},{"key":"2016010322452388000_133.4.602.26","doi-asserted-by":"crossref","unstructured":"Marin D Kaeda J Szydlo R Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse. Leukemia. 2005;19:507\u2013512.","DOI":"10.1038\/sj.leu.2403664"},{"key":"2016010322452388000_133.4.602.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030513"},{"key":"2016010322452388000_133.4.602.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0092"},{"key":"2016010322452388000_133.4.602.29","doi-asserted-by":"crossref","unstructured":"Radich JP Gehly G Gooley T Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood. 1995;85:2632\u20132638.","DOI":"10.1182\/blood.V85.9.2632.bloodjournal8592632"},{"key":"2016010322452388000_133.4.602.30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00823.x"},{"key":"2016010322452388000_133.4.602.31","doi-asserted-by":"publisher","DOI":"10.1038\/sj\/leu\/2401426"},{"key":"2016010322452388000_133.4.602.32","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf156"},{"key":"2016010322452388000_133.4.602.33","doi-asserted-by":"publisher","DOI":"10.1309\/60A9C8WGEGHRNXEE"},{"key":"2016010322452388000_133.4.602.34","unstructured":"Kreuzer KA Lass U Bohn A LightCycler technology for the quantitation of bcr\/abl fusion transcripts. Cancer Res. 1999;59:3171\u20133174."},{"key":"2016010322452388000_133.4.602.35","doi-asserted-by":"publisher","DOI":"10.1038\/sj\/leu\/2401566"},{"key":"2016010322452388000_133.4.602.36","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.02811.x"},{"key":"2016010322452388000_133.4.602.37","doi-asserted-by":"crossref","unstructured":"Stock W Yu D Karrison T Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples. Int J Oncol. 2006;28:1099\u20131103.","DOI":"10.3892\/ijo.28.5.1099"},{"key":"2016010322452388000_133.4.602.38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<741::AID-IJC22>3.0.CO;2-1"},{"key":"2016010322452388000_133.4.602.39","doi-asserted-by":"crossref","unstructured":"Barbany G Hagberg A Olsson-Stromberg U Manifold-assisted reverse transcription\u2013PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients. Clin Chem. 2000;46:913\u2013920.","DOI":"10.1093\/clinchem\/46.7.913"},{"key":"2016010322452388000_133.4.602.40","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.00556.x"},{"key":"2016010322452388000_133.4.602.41","unstructured":"Martinelli G Montefusco V Testoni N Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation. Haematologica. 2000;85:653\u2013658."},{"key":"2016010322452388000_133.4.602.42","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-1578(10)60007-4"},{"key":"2016010322452388000_133.4.602.43","unstructured":"Bolufer P Sanz GF Barragan E Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes. Haematologica. 2000;85:1248\u20131254."},{"key":"2016010322452388000_133.4.602.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2896"},{"key":"2016010322452388000_133.4.602.45","doi-asserted-by":"crossref","unstructured":"Dameshek W . Some speculations on the myeloproliferative disorders. Blood. 1951;6:372.","DOI":"10.1182\/blood.V6.4.372.372"},{"key":"2016010322452388000_133.4.602.46","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-6-200309160-00009"},{"key":"2016010322452388000_133.4.602.47","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.05.020"},{"key":"2016010322452388000_133.4.602.48","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1967.00300040030005"},{"key":"2016010322452388000_133.4.602.49","doi-asserted-by":"crossref","unstructured":"Ward HP Block MH . The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore). 1971;50:357\u2013420.","DOI":"10.1097\/00005792-197109000-00001"},{"key":"2016010322452388000_133.4.602.50","doi-asserted-by":"crossref","unstructured":"Varki A Lottenberg R Griffith R The syndrome of idiopathic myelofibrosis: a clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine (Baltimore). 1983;62:353\u2013371.","DOI":"10.1097\/00005792-198311000-00002"},{"key":"2016010322452388000_133.4.602.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421706"},{"key":"2016010322452388000_133.4.602.52","doi-asserted-by":"crossref","unstructured":"Barosi G . Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17:2954\u20132970.","DOI":"10.1200\/JCO.1999.17.9.2954"},{"key":"2016010322452388000_133.4.602.53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01262.x"},{"key":"2016010322452388000_133.4.602.54","doi-asserted-by":"crossref","unstructured":"Thiele J Kvasnicka HM Diehl V Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. Leuk Lymphoma. 1999;33:207\u2013218.","DOI":"10.3109\/10428199909058421"},{"key":"2016010322452388000_133.4.602.55","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000278"},{"key":"2016010322452388000_133.4.602.56","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609051762"},{"key":"2016010322452388000_133.4.602.57","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0158"},{"key":"2016010322452388000_133.4.602.58","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0141"},{"key":"2016010322452388000_133.4.602.59","unstructured":"Iland HJ Laszlo J Peterson P Essential thrombocythemia: clinical and laboratory characteristics at presentation. Trans Assoc Am Physicians. 1983;96:165\u2013174."},{"key":"2016010322452388000_133.4.602.60","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00003"},{"key":"2016010322452388000_133.4.602.61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198102193040801"},{"key":"2016010322452388000_133.4.602.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06674.x"},{"key":"2016010322452388000_133.4.602.63","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404500"},{"key":"2016010322452388000_133.4.602.64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"2016010322452388000_133.4.602.65","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"2016010322452388000_133.4.602.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"2016010322452388000_133.4.602.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"2016010322452388000_133.4.602.68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2087"},{"key":"2016010322452388000_133.4.602.69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1800"},{"key":"2016010322452388000_133.4.602.70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05776.x"},{"key":"2016010322452388000_133.4.602.71","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3395"},{"key":"2016010322452388000_133.4.602.72","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404854"},{"key":"2016010322452388000_133.4.602.73","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22663"},{"key":"2016010322452388000_133.4.602.74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05858.x"},{"key":"2016010322452388000_133.4.602.75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099184"},{"key":"2016010322452388000_133.4.602.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2006.12.009"},{"key":"2016010322452388000_133.4.602.77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-007146"},{"key":"2016010322452388000_133.4.602.78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601462103"},{"key":"2016010322452388000_133.4.602.79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06206.x"},{"key":"2016010322452388000_133.4.602.80","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-009605"},{"key":"2016010322452388000_133.4.602.81","doi-asserted-by":"crossref","unstructured":"Nussenzveig RH Swierczek SI Jelinek J Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol. 2007;35:32\u201338.","DOI":"10.1016\/j.exphem.2006.11.012"},{"key":"2016010322452388000_133.4.602.82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143602"},{"key":"2016010322452388000_133.4.602.83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-4852"},{"key":"2016010322452388000_133.4.602.84","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22240"},{"key":"2016010322452388000_133.4.602.85","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.229"},{"key":"2016010322452388000_133.4.602.86","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-062125"},{"key":"2016010322452388000_133.4.602.87","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-013748"},{"key":"2016010322452388000_133.4.602.88","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.47"},{"key":"2016010322452388000_133.4.602.89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205690"},{"key":"2016010322452388000_133.4.602.90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810069"},{"key":"2016010322452388000_133.4.602.91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00960.x"},{"key":"2016010322452388000_133.4.602.92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-107748"},{"key":"2016010322452388000_133.4.602.93","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404724"},{"key":"2016010322452388000_133.4.602.94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095703"},{"key":"2016010322452388000_133.4.602.95","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404007"},{"key":"2016010322452388000_133.4.602.96","doi-asserted-by":"publisher","DOI":"10.1309\/TK0XL917XK2VLRPQ"},{"key":"2016010322452388000_133.4.602.97","doi-asserted-by":"crossref","unstructured":"Olsen RJ Tang Z Farkas DH Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system. Arch Pathol Lab Med. 2006;130:997\u20131003.","DOI":"10.5858\/2006-130-997-DOTJMI"},{"key":"2016010322452388000_133.4.602.98","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256206"},{"key":"2016010322452388000_133.4.602.99","doi-asserted-by":"publisher","DOI":"10.1309\/LW7Q3739RBRMBXXP"},{"key":"2016010322452388000_133.4.602.100","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404861"},{"key":"2016010322452388000_133.4.602.101","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2006.050064"},{"key":"2016010322452388000_133.4.602.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.05.006"},{"key":"2016010322452388000_133.4.602.103","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2006.050128"},{"key":"2016010322452388000_133.4.602.104","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213338.25111.d3"},{"key":"2016010322452388000_133.4.602.105","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404292"},{"key":"2016010322452388000_133.4.602.106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065202"},{"key":"2016010322452388000_133.4.602.107","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501376200"},{"key":"2016010322452388000_133.4.602.108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-018879"},{"key":"2016010322452388000_133.4.602.109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"2016010322452388000_133.4.602.110","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.137"},{"key":"2016010322452388000_133.4.602.111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-131664"},{"key":"2016010322452388000_133.4.602.112","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404948"},{"key":"2016010322452388000_133.4.602.113","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404750"},{"key":"2016010322452388000_133.4.602.114","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5237.797"},{"key":"2016010322452388000_133.4.602.115","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.56"},{"key":"2016010322452388000_133.4.602.116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025217"},{"key":"2016010322452388000_133.4.602.117","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.12.1391"},{"key":"2016010322452388000_133.4.602.118","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404728"},{"key":"2016010322452388000_133.4.602.119","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404662"},{"key":"2016010322452388000_133.4.602.120","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90322-0"},{"key":"2016010322452388000_133.4.602.121","unstructured":"Kulkarni S Heath C Parker S Fusion of H4\/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL\u2013negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res. 2000;60:3592\u20133598."},{"key":"2016010322452388000_133.4.602.122","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10980"},{"key":"2016010322452388000_133.4.602.123","doi-asserted-by":"crossref","unstructured":"Inhorn RC Aster JC Roach SA A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood. 1995;85:1881\u20131887.","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881"},{"key":"2016010322452388000_133.4.602.124","doi-asserted-by":"publisher","DOI":"10.1159\/000046639"},{"key":"2016010322452388000_133.4.602.125","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-004457"},{"key":"2016010322452388000_133.4.602.126","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.2"},{"key":"2016010322452388000_133.4.602.127","doi-asserted-by":"publisher","DOI":"10.1159\/000140631"},{"key":"2016010322452388000_133.4.602.128","unstructured":"Tefferi A Pardanani A . Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep. 2004;3:197\u2013202."},{"key":"2016010322452388000_133.4.602.129","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01559.x"},{"key":"2016010322452388000_133.4.602.130","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116761"},{"key":"2016010322452388000_133.4.602.131","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12324"},{"key":"2016010322452388000_133.4.602.132","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00021-2"},{"key":"2016010322452388000_133.4.602.133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1609"},{"key":"2016010322452388000_133.4.602.134","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(99)00145-9"},{"key":"2016010322452388000_133.4.602.135","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-2-37"},{"key":"2016010322452388000_133.4.602.136","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.047928"},{"key":"2016010322452388000_133.4.602.137","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.37"},{"key":"2016010322452388000_133.4.602.138","unstructured":"Taniguchi M Nishida T Hirota S Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999;59:4297\u20134300."},{"key":"2016010322452388000_133.4.602.139","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577"},{"key":"2016010322452388000_133.4.602.140","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1741"},{"key":"2016010322452388000_133.4.602.141","unstructured":"Frost MJ Ferrao PT Hughes TP Juxtamembrane mutant V560GKit is more sensitive to imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther. 2002;1:1115\u20131124."},{"key":"2016010322452388000_133.4.602.142","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22187"},{"key":"2016010322452388000_133.4.602.143","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03234.x"},{"key":"2016010322452388000_133.4.602.144","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10490"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/4\/602\/4991314\/ajcpath133-0602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T20:54:39Z","timestamp":1635108879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/AJCPPPZ1WFVGNE4A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":144,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,4,1]]},"published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1309\/AJCPPPZ1WFVGNE4A"],"URL":"https:\/\/doi.org\/10.1309\/ajcpppz1wfvgne4a","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}